ROS1 and breast cancer: Finally, the potential of these particles in intracellular delivery of ros1- and egfr1-specific siRNAs was investigated through assessment of cytotoxicity in breast cancer cells, biodistribution study and tumor regression in a synergetic mouse model of breast cancer.